Study of SCB01A in Patient With Head and Neck Cancer

NCT02488629 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

5

Enrollment

INDUSTRY

Sponsor class

Conditions

Head and Neck Squamous Cell Carcinoma

Interventions

DRUG: SCB01A

Sponsor

SynCore Biotechnology Co., Ltd.